# Yargesa

NDC: 42799-709
Generic name: Miglustat
Labeler / Manufacturer: Edenbridge Pharmaceuticals LLC.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20200806

FDA application: ANDA209821

## Active ingredients

- MIGLUSTAT: 100 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"42799-709"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=42799-709
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2b371dfe-e2b0-47fe-b677-a7bde7149f87